Entremed (ENMD)

[compost]

"We are now considering whether to continue the current study or pursue additional options such as a randomized Phase 2 study in patients with non-small cell lung cancer. We will continue to collect data over the next few months from patients participating in this trial to determine the most efficient path forward in this indication."
In my opinion these statements by Dr Sidor make it sound positive. She offers the choice of continuing the current study or changing to a more advanced study. There wasn't any option listed for closing the study.....
She indicates in the second sentence that they see the need to move 'forward in this indication'. Again, in my opinion, I can't imagine 'moving forward' would include abandoning this population.
On the other hand, regardless of the results of this trial so far, we are still on the brink financially. This news doesn't do anything to change that.